In this interview with Cure Today, IMF Chief Medical Officer Dr. Joseph Mikhael discusses recent advancements in stem cell mobilization in autologous stem cell transplants. These advancements involve using G-CSF and Aphexda in combination to improve stem cell collection efficiency compared to G-CSF alone. This modern approach avoids the need for invasive bone marrow harvesting, as stem cells can be mobilized from the bone marrow into the peripheral blood. Visit the full interview to learn more.